The secretion of abnormal monoclonal immunoglobulins (Igs) usually characterizes plasma cell dyscrasias. This can give rise to a variety of complications ranging from cast nephropathy to various forms of monoclonal Ig deposition diseases. 1, 2 Specifically, in the heart, Igs can be deposited as AL amyloid, light-chain deposition disease or light-and heavy-chain deposition disease. 3 Congo Red and Thioflavin T positivity as well as nonbranching fibrillary structure of the protein deposition by electron microscopic (EM) evaluation characterizes amyloidosis. However, if the deposits are Congo Red and Thioflavin T negative, amorphous granular electron-dense deposits by EM and positive by immunofluorescence studies for light and/or heavy chains, it is designated cardiac nonamyloidotic Ig deposition disease (CIDD). Synonyms include light chain or light-and heavy-chain deposition disease. In this review, we restrict the term Ig deposition disease to the nonamyloidotic light chain or light-and heavy-chain deposition type. We report the clinical features, light, immunofluorescent and EM findings of eight patients who have CIDD diagnosed by myocardial biopsy. This is the largest series of such patients reported in literature to date to the best of our knowledge.
Patients and methods
For this study, we retrospectively collected the pathology reports of all the endomyocardial biopsies performed at our institutions. The biopsy results were then reviewed and all the patients referred for biopsy to rule out cardiac amyloidosis were identified. Of these patients, those with CIDD were then studied in detail by chart review.
Initial evaluation of all the patients included a detailed history and physical examination along with a comprehensive laboratory evaluation, which included complete blood counts, serum electrolytes, creatinine, 24-h creatinine clearance, serum and urine protein electrophoresis with immunofixation studies. All the patients had a bone marrow aspirate and biopsy, skeletal surveys and skull, spine and pelvis magnetic resonance imaging (MRI). Electrocardiogram and transthoracic echocardiography to evaluate cardiac function were also carried out. Patients with clinical symptoms or signs suggestive of amyloidosis underwent biopsy of the relevant organs on the discretion of the attending oncologist and consulting physicians (usually a cardiologist or a nephrologist). The indications for a biopsy included diastolic dysfunction, low ejection fraction, involvement of other areas by amyloid or for prognostication as documented in the patient chart.
The biopsy was processed for light, immunofluorescence and EM studies.
Endomyocardial biopsies for light microscopy were formalin fixed (10% neutral-buffered formalin) and processed for hematoxylin and eosin (H&E) staining. Congo Red and Thioflavin T stains to assess amyloid deposition were also performed. A portion of the biopsy was snap frozen in liquid nitrogen and immunofluorescent staining for IgG, IgA, IgM, k and l light chains were performed. EM studies were carried out on glutaraldehyde-fixed material. Amyloidosis was defined as the presence of fibrillar material in the cardiac interstitium or vascular walls that was Congo Red and Thioflavin T positive. CIDD was defined as the presence of immunofluorescent Ig deposition in the cardiac interstitium or vascular walls in the absence of amyloid as evaluated by Congo Red, Thioflavin T and EM examination. The EM showed granular electron-dense deposits. Results are summarized in Table 1 . The eight patients with Ig deposition disease had a median age of 49.5 years (range 40-64 years). There were five males and three females. All patients had plasma cell dyscrasias, five with diagnostic criteria of multiple myeloma, two meeting the diagnostic criteria for smoldering myeloma and one patient referred for amyloidosis. Three patients had IgG l, two with IgG k, and one each IgD k, k and l monoclonal protein.
Results

One of the institutions (University of Arkansas for
None of the patients were symptomatic from their cardiac Ig deposition at presentation. However, on echocardiography, six patients had concentric left ventricular hypertrophy with diastolic dysfunction. Interventricular septal thickness was 15 mm in the four patients where it could be measured accurately (range 11-18). In two patients, the echocardiographic studies were reported as normal. Four patients had hypertension and four did not.
Endomyocardial biopsies of all eight patients had normal appearing myocardium on light microscopy H&E stains (Figure 1 ). Congo Red (Figure 2 ) and Thioflavin T stains as well as EM examination were negative for amyloidosis. Immunofluorescent staining of the cardiac biopsies, IgG was present in four patients and IgD in one patient (Figure 3 ). Four were positive for l light chains and four for k light chains corresponding to the light chain found in the patient's serum. The deposits were seen primarily in the interstitium. Positive IgG heavychain staining was seen in four of the five patients with IgG heavy chain. On EM, five patients had granular electron-dense deposits in the interstitium (Figure 4 ), and two patients had normal myocardium by EM. One did not have EM studies available for review.
Interestingly, four patients had concurrent amyloidosis involving other organs. Four patients had renal biopsies to evaluate proteinuria. Of these, two had renal amyloidosis and two had light-chain deposition disease. Four patients had an abdominal fat pad aspirate, one of which showed Congo Redpositive amyloid deposits. Two patients had gastrointestinal involvement with amyloid. Two patients had amyloid deposition identified in their bone marrow.
One patient was noted to have had an episode of 15 s, 42 beat run of spontaneous asymptomatic ventricular tachycardia when undergoing cardiac monitoring after admission for a presyncopal event, which occurred during chemotherapy administration (infusional cyclophosphamide, adriamycin, dexamethasone). Given his documented CIDD and this clinical event, an implanted cardioverter defibrillator device was placed. Another patient developed atrial fibrillation during chemotherapy (infusional cyclophosphamide, etoposide, dexamethasone and cisplatin). He responded to therapy with digoxin. Arrhythmogenesis during infusional chemotherapy in patients with CIDD has not been reported before. We do not know if this is truly related to each other or whether it is a random association at this time. One report of this deposition associated with marked systemic calcification is also noted in the literature. 12 Ig deposition in the myocardium is an uncommon but well described entity. [1] [2] [3] [7] [8] [9] The nonfibrillar Ig deposition may be composed of light chains, heavy chains or both. As is seen in our study, the Igs may be deposited as amyloid concurrently in other organs, specifically kidney, gastrointestinal tract, abdominal fat pad or bone marrow. The mechanisms by which in some patients the light chains assume a fibrillar configuration and hence form amyloid, and do not do so in others and also why they assume varied structure in different organs of the same patient are not completely clear at this time.
Gallo and Vidal et al 13, 14 did biochemical analysis of the nonfibrillar-type of k light chains deposited in the cardiac interstitium. They suggest that somatic mutations of specific amino-acid sequences in the light chains affect the folding and three-dimensional structure of the protein. This may determine the nature of light-chain tissue deposition. Based on in vivo and in vitro data, they postulate that Ig deposition disease may be an arrested form of preamyloid in the pathway of amyloid formation. However, the role of cardiac interstitium and cytokines in this interaction needs further study. In vitro studies in the kidneys by Herrera et al show that processing of the Ig by the mesangial cell and subsequent cellular signaling pathways play an important role in the distinction of the deposits. 15, 16 AL amyloidosis can manifest as diastolic dysfunction, conduction abnormalities or congestive cardiac failure. Our series show that incidence of CIDD is almost as frequent as AL amyloidosis in patients with plasma cell dyscrasias (31 vs 39%). There appears to be no specific lightor heavy-chain predilection. Concurrent involvement by amyloid in other organs suggests the role of local tissue and cellular interactions in the morphologic manifestations of monoclonal Ig deposition. Not all patients with CIDD are clinically symptomatic.
The clinical manifestations include left ventricular hypertrophy (in the absence of hypertension), diastolic dysfunction and arrhythmias. Immunofluorescence and EM studies are diagnostic and should be considered in all patients with plasma cell dyscrasias undergoing myocardial biopsy and work-up.
Conclusion
CIDD is an uncommon complication of plasma cell dyscrasias. This diagnosis has to be considered in the differential diagnosis of such patients with cardiac dysfunction. Adequate sampling for EM and immunofluorescence studies of the myocardial biopsy is necessary to diagnose this entity. Clinically, these patients may be asymptomatic, at risk for developing arrhythmias or diastolic dysfunction. Our series also demonstrates the concurrent involvement of amyloid and light chain or light-and heavy-chain deposition in various organs sampled at the same time point. This may support the evolving theory of the role of local microenvironment in the pathogenesis of systemic diseases. 
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